Discover tesamorelin dosage trends, reconstitution volumes, and vial size preferences based on real-world WPA calculator data.
Tesamorelin is a stabilized GHRH analog with a well-characterized growth hormone release profile, typically administered via nightly subcutaneous injection. This data shows the dose amounts, vial sizes, and bacteriostatic water volumes researchers most commonly select when reconstituting this GHRH-based peptide.
3,290 Tesamorelin reconstitution calculations have been logged by the WPA community. The most common dose entered is 2mg (1,125 calculations). The median dose across all sessions is 1mg. The most common bacteriostatic water volume is 2mL. The most popular vial size is 10mg (2,018 sessions). The most common dosing frequency is daily (7x/week) (404 logged protocols), followed by 5x/week (257).
World Peptide Association aggregates anonymized peptide calculator data to show real-world dosing trends, reconstitution volumes, and vial size preferences across the research peptide community.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.